Demand for aspiration and biopsy needles in USA is projected to grow from USD 325.7 million in 2026 to USD 572.2 million by 2036, expanding at a CAGR of 5.8%. Biopsy needles account for 55.0% share in 2026 within the product-type segment. Tumour and cancer applications represent 43.0% share in the application segment.